Clinical Trial Update: Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gemcitabine with or without WX-671 in locally advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• WX-671

Snippet

Sponsor: Heidelberg Pharma AG | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED